Ra. Blaheta et al., ADHESION AND PENETRATION PROPERTIES OF HUMAN-LYMPHOCYTES ACTING ON ALLOGENEIC VASCULAR ENDOTHELIAL-CELLS, Immunology, 81(4), 1994, pp. 538-545
Lymphocyte infiltration through vascular endothelium is one important
step in the course of graft rejection. To investigate this process mor
e exactly we established a monolayer invasion assay which enabled us t
o discriminate between adherent and penetrated cells. Detailed studies
of adhesion and penetration kinetics of peripheral blood lymphocytes
(PBL) acting on allogeneic human umbilical vein endothelial cells (HUV
EC) were carried out by combined phase contrast and reflection interfe
rence contrast microscopy. Between 30 and 35% of all PBL attached to H
UVEC after 4 hr. Out of these less than 10% penetrated. When HUVEC wer
e prestimulated for 2 hr by interferon (IFN)-alpha, -beta, -gamma or i
nterleukin (IL)-1, PBL adhesion in the early phase of cellular attachm
ent to endothelial cells was accelerated. Overall adhesion however did
not increase. Long-term pretreatment of HUVEC for 72 hr with IFN-gamm
a or IL-1 also modified PBL-HUVEC interactions. However, a 72-hr pretr
eatment with IFN-alpha or -beta did not influence lymphocyte binding b
ehaviour. PBL penetration was not only accelerated but also enhanced b
y IFN-alpha, -beta, -gamma, irrespective of whether HUVEC were prestim
ulated for 2 hr or PBL and cytokines were added simultaneously to HUVE
C. On the other hand IL-1 was not able to enhance the amount of penetr
ated cells but only accelerated the infiltration process. Upregulation
or de novo expression of the adhesion molecules ICAM-1 (intercellular
adhesion molecule), ELAM-1 (endothelial leucocyte adhesion molecule)
and VCAM-1 (vascular cell adhesion molecule) did not parallel PBL bind
ing kinetics. Therefore an ICAM-, ELAM- and VCAM-independent modulatio
n in the early phase of lymphocyte attachment to endothelium seems lik
ely. The lymphocyte cytoskeleton may have a role in this process.